ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse
- Resource Type
- Article
- Source
- In
Clinical Gastroenterology and Hepatology May 2024 22(5):1077-1086 - Subject
- Language
- ISSN
- 1542-3565